{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:09:13Z","timestamp":1747148953840,"version":"3.40.5"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1002\/hep.30768","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T18:48:59Z","timestamp":1558032539000},"page":"1473-1476","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mammalian Target of Rapamycin Inhibitors, New Drugs for Beta\u2010Catenin\u2013Mutated Hepatocellular Carcinomas?"],"prefix":"10.1097","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4710-7051","authenticated-orcid":false,"given":"Christine","family":"Perret","sequence":"first","affiliation":[{"name":"INSERM, U1016, Institut Cochin,Paris,France"},{"name":"CNRS, UMR8104,Paris,France"},{"name":"Universit\u00e9 Paris Descartes Sorbonne Paris Cit\u00e9,Paris,France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Decaens","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Grenoble Alpes,Grenoble,France"},{"name":"Service d\u2019H\u00e9pato\u2010gastroent\u00e9rologie, P\u00f4le Digidune, CHU Grenoble Alpes,Grenoble,France"},{"name":"Institute for Advanced Biosciences,Research Center UGA\/Inserm U 1209\/CNRS 5309,Grenoble,France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"hep30768-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","year":"2015","journal-title":"Nat Genet"},{"key":"hep30768-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","article-title":"Inhibiting glutamine\u2010dependent mTORC1 activation ameliorates liver cancers driven by beta\u2010catenin mutations","volume":"29","year":"2019","journal-title":"Cell Metab"},{"key":"hep30768-bib-0003-20241017","first-page":"63","article-title":"Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish","volume":"7","year":"2014","journal-title":"Dis Model Mech"},{"key":"hep30768-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.devcel.2006.03.015","article-title":"Apc tumor suppressor gene is the \"zonation\u2010keeper\" of mouse liver","volume":"10","year":"2006","journal-title":"Dev Cell"},{"key":"hep30768-bib-0005-20241017","first-page":"E10362","article-title":"mTORC1 signaling suppresses Wnt\/beta\u2010catenin signaling through DVL\u2010dependent regulation of Wnt receptor FZD level","volume":"115","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep30768-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature13896","article-title":"mTORC1\u2010mediated translational elongation limits intestinal tumour initiation and growth","volume":"517","year":"2015","journal-title":"Nature"},{"key":"hep30768-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ajpath.2017.07.005","article-title":"Thyroid hormone receptor\u2010beta agonist GC\u20101 inhibits met\u2010beta\u2010catenin\u2010driven hepatocellular cancer","volume":"187","year":"2017","journal-title":"Am J Pathol"},{"key":"hep30768-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","article-title":"Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends","volume":"60","year":"2014","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.30768","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.30768","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.30768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T23:22:40Z","timestamp":1729207360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.30768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.30768","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"type":"print","value":"0270-9139"},{"type":"electronic","value":"1527-3350"}],"subject":[],"published":{"date-parts":[[2019,5,16]]}}}